Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-25-326992
Filing Date
2025-12-19
Accepted
2025-12-19 16:46:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM d31349dposam.htm POS AM 501143
2 EX-23.1 d31349dex231.htm EX-23.1 2689
3 GRAPHIC g31349g61x04.jpg GRAPHIC 37665
  Complete submission text file 0001193125-25-326992.txt   549405
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-276774 | Film No.: 251588202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)